Evaxion Biotech A/S Reports Convincing One-Year Data from Phase 2 Trial on AI-Designed ...

Retrieved on: 2024-09-16 18:55:20

Tags for this article:

Click the tags to see associated articles and topics

Evaxion Biotech A/S Reports Convincing One-Year Data from Phase 2 Trial on AI-Designed .... View article details on hiswai:

Excerpt

As a neoantigen vaccine, EVX-01 aims at triggering the patient?s immune system to target these specific antigens and thereby eradicate the cancer ...

Article found on: www.marketscreener.com